News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
261,735 Results
Type
Article (13949)
Company Profile (304)
Press Release (247482)
Section
Business (79356)
Career Advice (151)
Deals (13190)
Drug Delivery (34)
Drug Development (50331)
Employer Resources (31)
FDA (5682)
Job Trends (5116)
News (144137)
Policy (10018)
Tag
Academia (901)
Alliances (21525)
Alzheimer's disease (758)
Approvals (5665)
Artificial intelligence (68)
Bankruptcy (97)
Best Places to Work (4522)
Biotechnology (249)
Breast cancer (109)
Cancer (890)
Cardiovascular disease (71)
Career advice (132)
CAR-T (73)
Cell therapy (217)
Clinical research (40139)
Collaboration (311)
Compensation (129)
COVID-19 (1006)
C-suite (78)
Cystic fibrosis (67)
Data (984)
Diabetes (87)
Diagnostics (1207)
Drug discovery (57)
Earnings (29005)
Events (47193)
Executive appointments (247)
FDA (6054)
Funding (306)
Gene editing (63)
Gene therapy (163)
GLP-1 (311)
Government (1065)
Healthcare (6543)
Infectious disease (1044)
Inflammatory bowel disease (98)
IPO (7197)
Job creations (859)
Job search strategy (127)
Layoffs (188)
Legal (1375)
Lung cancer (130)
Lymphoma (62)
Manufacturing (87)
Medical device (2559)
Medtech (2560)
Mergers & acquisitions (6128)
Metabolic disorders (260)
Neuroscience (1001)
NextGen Class of 2024 (2004)
Non-profit (847)
Northern California (1092)
Obesity (140)
Opinion (91)
Parkinson's disease (76)
Patents (61)
People (25106)
Phase I (14151)
Phase II (18664)
Phase III (11819)
Pipeline (367)
Postmarket research (851)
Preclinical (5971)
Radiopharmaceuticals (205)
Rare diseases (202)
Real estate (1409)
Regulatory (8289)
Research institute (931)
Southern California (976)
Startups (1964)
United States (8670)
Vaccines (165)
Weight loss (84)
Date
Today (24)
Last 7 days (362)
Last 30 days (1397)
Last 365 days (20551)
2024 (20463)
2023 (22413)
2022 (26822)
2021 (27805)
2020 (23357)
2019 (16225)
2018 (11738)
2017 (13745)
2016 (11839)
2015 (14349)
2014 (10392)
2013 (7484)
2012 (7532)
2011 (7614)
2010 (7428)
Location
Africa (146)
Asia (16925)
Australia (2856)
California (2475)
Canada (809)
China (204)
Colorado (91)
Connecticut (104)
Europe (36449)
Florida (272)
Georgia (71)
Illinois (154)
Indiana (61)
Maryland (332)
Massachusetts (1957)
Michigan (56)
Minnesota (101)
New Jersey (631)
New York (684)
North Carolina (419)
Northern California (1092)
Ohio (82)
Pennsylvania (474)
South America (207)
Southern California (976)
Texas (279)
Washington State (248)
261,735 Results for "tennor therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
TenNor Announces Positive Topline Results from Rifasutenizol Phase III Trial for H. pylori Infection
November 18, 2024
·
4 min read
Press Releases
TenNor Announces More than 300 Million RMB Financing to Support Development and Commercialization of Late-Stage Assets Including Rifasutenizol for Heliobacter pylori Infections
October 16, 2024
·
4 min read
Drug Development
TenNor Reports Positive Results of TNP-2092 Capsule for the Treatment of Liver Cirrhosis Hyperammonemia
TenNor Therapeutics reports positive top-line results for TNP-2092 Capsule from a phase II clinical trial for the treatment of hyperammonemia/hepatic encephalopathy in patients with liver cirrhosis.
November 22, 2021
·
5 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
TenNor Therapeutics Received FDA Orphan Drug Designation
TenNor Therapeutics, a clinical-stage, global biopharmaceutical company has received FDA Orphan Drug Designation for TNP-2092 to treat prosthetic joint infections.
January 20, 2020
·
1 min read
Business
TenNor Enters Research Collaboration with Janssen for Potential New Treatments for Nontuberculous Mycobacteria Diseases
TenNor Therapeutics (Suzhou) Limited, a clinical-stage biopharmaceutical company dedicated to research and development of differentiated products for the treatment of diseases associated with bacterial infections and dysbioses, announced today that it has entered into a research collaboration agreement with Janssen Pharmaceuticals, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson.
January 18, 2021
·
2 min read
Drug Development
TenNor Therapeutics Reported Phase II Top-Line Results for TNP-2092
TenNor Therapeutics reported positive top-line results for TNP-2092 powder for injection from a phase II clinical trial conducted in the United States.
November 11, 2019
·
3 min read
Regulatory
FDA Warns Applied Therapeutics of ‘Objectionable Conditions’ in Govorestat Study
The agency’s warning letter outlines Applied Therapeutics’ failure to provide adequate information regarding the clinical trial—including a dosing error for govorestat—claims that the company said it had already addressed.
December 4, 2024
·
2 min read
·
Tristan Manalac
Press Releases
NeuroEM Therapeutics(R) Accepted into StartUp Health’s Alzheimer’s Moonshot Community(TM)
September 19, 2024
·
4 min read
Press Releases
Cara Therapeutics and Tvardi Therapeutics Announce Entry into Merger Agreement
December 18, 2024
·
16 min read
1 of 26,174
Next
